1. Home
  2. MLYS vs CENT Comparison

MLYS vs CENT Comparison

Compare MLYS & CENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$29.38

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Central Garden & Pet Company

CENT

Central Garden & Pet Company

HOLD

Current Price

$38.91

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
CENT
Founded
2019
1955
Country
United States
United States
Employees
N/A
6000
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.4B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MLYS
CENT
Price
$29.38
$38.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$47.33
$50.00
AVG Volume (30 Days)
1.0M
71.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.60
Revenue Next Year
N/A
$2.04
P/E Ratio
N/A
$15.73
Revenue Growth
N/A
N/A
52 Week Low
$8.79
$28.77
52 Week High
$47.65
$41.25

Technical Indicators

Market Signals
Indicator
MLYS
CENT
Relative Strength Index (RSI) 45.18 65.17
Support Level $26.85 $31.71
Resistance Level $32.21 $40.81
Average True Range (ATR) 1.46 1.02
MACD 0.27 -0.07
Stochastic Oscillator 46.46 61.77

Price Performance

Historical Comparison
MLYS
CENT

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About CENT Central Garden & Pet Company

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

Share on Social Networks: